These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34698949)

  • 21. The pathological and outcome characteristics of renal lesions in Crohn's disease.
    Yang Z; Xu X; Dong Y; Zhang Y
    BMC Nephrol; 2022 Jul; 23(1):256. PubMed ID: 35850695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very-early-onset inflammatory bowel disease versus late-onset inflammatory bowel disease in relation to clinical phenotype: A cross-sectional study.
    Mansour HH; Seddek SS; Meguid MEAEL; Eskander AE; Galal ST
    Indian J Gastroenterol; 2023 Apr; 42(2):185-191. PubMed ID: 37166697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era.
    Dincer MT; Dincer ZT; Bakkaloglu OK; Yalin SF; Trabulus S; Celik AF; Seyahi N; Altiparmak MR
    Med Sci Monit; 2022 Jul; 28():e936497. PubMed ID: 35791280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ulcerative colitis or Crohn's disease? Pitfalls and problems.
    Feakins RM
    Histopathology; 2014 Feb; 64(3):317-35. PubMed ID: 24266813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarities and differences in clinical and pathologic features of inflammatory bowel disease-associated colorectal cancer in China and Canada.
    Li J; Zhou WX; Liu S; Zheng WY; Wang YN; Li JN; Ferraz JG; Qian JM; Gui XY
    Chin Med J (Engl); 2019 Nov; 132(22):2664-2669. PubMed ID: 31725457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FACTORS ASSOCIATED WITH CIRCULATING ZONULIN IN INFLAMMATORY BOWEL DISEASE.
    Lacombe LAC; Matiollo C; Rosa JSD; Felisberto M; Dalmarco EM; Schiavon LL
    Arq Gastroenterol; 2022; 59(2):238-243. PubMed ID: 35830035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
    Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
    BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status of Cytomegalovirus Colitis Among Patients With Inflammatory Bowel Disease in China: A Questionnaire-Based Multicenter Study.
    Yang H; Qian J
    Inflamm Bowel Dis; 2022 Jun; 28(Suppl 2):S45-S51. PubMed ID: 34984462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study.
    Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B
    Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary manifestations of inflammatory bowel disease.
    Storch I; Sachar D; Katz S
    Inflamm Bowel Dis; 2003 Mar; 9(2):104-15. PubMed ID: 12769444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the Quality of Life of Patients Recently Diagnosed with Crohn's Disease and Ulcerative Colitis.
    Bernabéu Juan P; Cabezos Sirvent P; Sempere Robles L; van-der Hofstadt Gomis A; Rodríguez Marín J; van-der Hofstadt Román CJ
    Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
    Lo B; Julsgaard M; Vester-Andersen MK; Vind I; Burisch J
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1130-1136. PubMed ID: 29979218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.